About Us
About Us
About IBS
Clinical Trial
Products
Investments
Investment Centre
ASX Announcements
Corporate Docs
News & Media
References
Contact
About Us
About Us
About IBS
Clinical Trial
Products
Investments
Investment Centre
ASX Announcements
Corporate Docs
News & Media
References
Contact
Investor Home
Corporate Directory
Anatara Lifesciences LTD
ACN 145 239 872
ABN 41 145 239 872
Directors
Dr David Brookes
Executive Chair
Nicholas Haslam
Non-Executive Director
John Michailidis
Executive Director
Executive Chair
Dr David Brookes
+ 61 (0)411 712 579
dbrookes@anatara.com
Office Address
Anatara Lifesciences Ltd
Registered Office – C-Perks Level 8, 81 Flinders Street, Adelaide SA 5000, Australia
ASX Announcements
Corporate Factsheet
Analysts' Reports
Annual Reports
Financial Reports
Presentations
Events
Corporate Governance
Company Secretary
Mr Stephen Denaro
+ 61 (0)413 453 506
sdenaro@triobi.com.au
Corporate Attorneys
Thomson Geer
Waterfront Place, Level 16, 1 Eagle Street, Brisbane QLD 4000
Company Auditors
Grant Thornton
Collins Square, Tower 5/727 Collins Street, Melbourne VIC 3008
Investor Relations
Dr David Brookes
+ 61 (0)411 712 579
dbrookes@anatara.com
ASX Announcements
Corporate Factsheet
Analysts' Reports
Annual Reports
Financial Reports
Presentations
Events
Corporate Governance
Evidence-based treatments for gastrointestinal health
About Us
Products
Investments
News & Media
Contact Us
Want to stay up to date with our trials and latest news?
Sign up here
All rights reserved © Anatara Lifesciences 2024